The longevity field has evolved significantly in the last few years. The recent Aging Research & Drug Discovery Meeting in Copenhagen highlighted the substantial progress made in this area.
Recently, our managing partner, Sergey Jakimov, met with Jess Larsen at his Innovation and Leadership podcast. Sergey recounted his personal background and described how he, Garri Zmudze, and Ilya Suharenko co-founded LongeVC. At present, we are already closing our Fund I and are mapping out plans for a $250M Fund II.
Sergey and Jess delved into topics such as investments in longevity, the role of AI in drug discovery, and developments in the biopharmaceutical industry. Sergey also shared insights into some of our portfolio companies, including Rubedo Life Sciences and Turn Biotechnologies.
You can listen to the whole episode here.
Recently, our managing partner, Sergey Jakimov, met with Jess Larsen at his Innovation and Leadership podcast. Sergey recounted his personal background and described how he, Garri Zmudze, and Ilya Suharenko co-founded LongeVC. At present, we are already closing our Fund I and are mapping out plans for a $250M Fund II.
Sergey and Jess delved into topics such as investments in longevity, the role of AI in drug discovery, and developments in the biopharmaceutical industry. Sergey also shared insights into some of our portfolio companies, including Rubedo Life Sciences and Turn Biotechnologies.
You can listen to the whole episode here.